Fate Therapeutics Inc (FATE):企業の財務・戦略的SWOT分析

◆英語タイトル:Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH137961FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Fate Therapeutics Inc (FATE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company’s pipeline includes various Off-the-shelf, iPSC-derived cellular immunotherapies for the treatment of several Hematologic Malignancies and advanced solid tumors. Its pipeline also include donor-derived cell product candidate for the treatment of Hematologic Malignancies. Fate uses its proprietary human induced pluripotent stem cells (iPSCs) platform for the product development. The company also has research collaborations with companies, academic and medical centers for the advancements of products and technologies. Fate Therapeutics is headquarterd in San Diego, California, the US.

Fate Therapeutics Inc Key Recent Developments

Mar 25,2021: Fate Therapeutics Announces Retirement of Chief Scientific Officer after 12 Years of Service
Mar 08,2021: Fate Therapeutics to Present at Upcoming Investor Conferences
Feb 24,2021: Fate Therapeutics reports fourth quarter 2020 financial results and highlights operational progress
Feb 22,2021: Fate Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Feb 19,2021: Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2020 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Fate Therapeutics Inc – Key Facts
Fate Therapeutics Inc – Key Employees
Fate Therapeutics Inc – Key Employee Biographies
Fate Therapeutics Inc – Major Products and Services
Fate Therapeutics Inc – History
Fate Therapeutics Inc – Company Statement
Fate Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Fate Therapeutics Inc – Business Description
Fate Therapeutics Inc – Corporate Strategy
Fate Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Fate Therapeutics Inc – Strengths
Fate Therapeutics Inc – Weaknesses
Fate Therapeutics Inc – Opportunities
Fate Therapeutics Inc – Threats
Fate Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fate Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 25, 2021: Fate Therapeutics Announces Retirement of Chief Scientific Officer after 12 Years of Service
Mar 08, 2021: Fate Therapeutics to Present at Upcoming Investor Conferences
Feb 24, 2021: Fate Therapeutics reports fourth quarter 2020 financial results and highlights operational progress
Feb 22, 2021: Fate Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Feb 19, 2021: Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2020 Financial Results
Nov 05, 2020: Fate Therapeutics announces twelve presentations at the 2020 ASH Annual Meeting
Nov 05, 2020: Fate Therapeutics reports third quarter 2020 financial results and highlights operational progress
Aug 19, 2020: Fate Therapeutics appoints Edward Dulac as Chief Financial Officer
Aug 05, 2020: Fate Therapeutics reports second quarter 2020 financial results and highlights operational progress
May 11, 2020: Fate Therapeutics reports first quarter 2020 financial results and highlights operational progress
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Fate Therapeutics Inc, Key Facts
Fate Therapeutics Inc, Key Employees
Fate Therapeutics Inc, Key Employee Biographies
Fate Therapeutics Inc, Major Products and Services
Fate Therapeutics Inc, History
Fate Therapeutics Inc, Subsidiaries
Fate Therapeutics Inc, Key Competitors
Fate Therapeutics Inc, Ratios based on current share price
Fate Therapeutics Inc, Annual Ratios
Fate Therapeutics Inc, Annual Ratios (Cont...1)
Fate Therapeutics Inc, Interim Ratios
Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fate Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fate Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Fate Therapeutics Inc (FATE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Coventry Group Ltd (CYG):企業の財務・戦略的SWOT分析
    Coventry Group Ltd (CYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lego AS:企業の戦略的SWOT分析
    Lego AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Amoy Diagnostics Co Ltd (300685):医療機器:M&Aディール及び事業提携情報
    Summary Amoy Diagnostics Co Ltd (AmoyDx) is a developer of molecular diagnostics for oncology precision medicine. The company provides gene mutation products such as mutation detection kit and gene fusions detection kit. It offers nucleic acid extraction products including DNA and RNA extraction kit …
  • Kingdom Hotel Investments:企業の戦略・SWOT・財務分析
    Kingdom Hotel Investments - Strategy, SWOT and Corporate Finance Report Summary Kingdom Hotel Investments - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Electric Power Development Co Ltd (9513):企業の財務・戦略的SWOT分析
    Electric Power Development Co Ltd (9513) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Abiomed Inc (ABMD)-医療機器分野:企業M&A・提携分析
    Summary Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes catheters for cir …
  • DiamondRock Hospitality Co:戦略・SWOT・企業財務分析
    DiamondRock Hospitality Co - Strategy, SWOT and Corporate Finance Report Summary DiamondRock Hospitality Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • DASAN ZHONE SOLUTIONS, INC.:企業の戦略・SWOT・財務情報
    DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report Summary DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Paddy Power Betfair Plc:企業の戦略・SWOT・財務分析
    Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report Summary Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Thomas Cook Group plc:企業の戦略・SWOT・財務情報
    Thomas Cook Group plc - Strategy, SWOT and Corporate Finance Report Summary Thomas Cook Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pier 1 Imports, Inc.:企業の戦略・SWOT・財務情報
    Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Electricite du Liban:企業の戦略的SWOT分析
    Electricite du Liban - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • London Stock Exchange Group Plc:企業のM&A・事業提携・投資動向
    London Stock Exchange Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's London Stock Exchange Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • InterOil Exploration & Production ASA (IOX):企業の財務・戦略的SWOT分析
    Summary InterOil Exploration & Production ASA (InterOil Exploration & Production) is an oil and gas company that provides petroleum exploration services. The company acquires, explores, develops and operates oil and natural gas properties, among others. It operates as an active license partner in se …
  • Dentsply Sirona Inc (XRAY):医療機器:M&Aディール及び事業提携情報
    Summary Dentsply Sirona Inc (Dentsply Sirona) formerly Dentsply International Inc, is a medical device company that designs, develops, manufactures and markets a wide range of products for the dental market. It provides dental prosthetics, precious metal dental alloys, dental ceramics, endodontic in …
  • DesignMedix Inc-製薬・医療分野:企業M&A・提携分析
    Summary DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases including malaria and diarrhea. The company focuses on the development of malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. Its malaria cure drugs …
  • Kokuyo Camlin Ltd (KOKUYOCMLN):企業の財務・戦略的SWOT分析
    Kokuyo Camlin Ltd (KOKUYOCMLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Air Products and Chemicals, Inc.:企業の戦略・SWOT・財務情報
    Air Products and Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Air Products and Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Sernova Corp (SVA):製品パイプライン分析
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company is developing Cell Pouch System, an implantable medical device, which offers a natural organ- …
  • Dauntless Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dauntless Pharmaceuticals Inc (Dauntless Pharma) is a drug development company that develops therapeutic agents. The company’s pipeline products include DP1038 and DP2018. Its DP1038 is an intranasal octreotide formulation used as a therapeutic agent for the treatment of acromegaly and neuro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆